Authors:
Silins, SL
Sherritt, MA
Silleri, JM
Cross, SM
Elliott, SL
Bharadwaj, M
Le, TTT
Morrison, LE
Khanna, R
Moss, DJ
Suhrbier, A
Misko, LS
Citation: Sl. Silins et al., Asymptomatic primary Epstein-Barr virus infection occurs in the absence ofblood T-cell repertoire perturbations despite high levels of systemic viral load, BLOOD, 98(13), 2001, pp. 3739-3744
Authors:
Moss, DJ
Khanna, R
Sherritt, M
Elliott, SL
Burrows, SR
Citation: Dj. Moss et al., Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies, J ACQ IMM D, 21, 1999, pp. S80-S83
Authors:
Elliott, SL
Pye, S
Le, T
Mateo, L
Cox, J
Macdonald, L
Scalzo, AA
Forbes, CA
Suhrbier, A
Citation: Sl. Elliott et al., Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems, VACCINE, 17(15-16), 1999, pp. 2009-2019
Authors:
Misko, IS
Cross, SM
Khanna, R
Elliott, SL
Schmidt, C
Pye, SJ
Silins, SL
Citation: Is. Misko et al., Crossreactive recognition of viral, self, and bacterial peptide ligands byhuman class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease, P NAS US, 96(5), 1999, pp. 2279-2284
Authors:
Khanna, R
Bell, S
Sherritt, M
Galbraith, A
Burrows, SR
Rafter, L
Clarke, B
Slaughter, R
Falk, MC
Douglass, J
Williams, T
Elliott, SL
Moss, DJ
Citation: R. Khanna et al., Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease, P NAS US, 96(18), 1999, pp. 10391-10396